全文获取类型
收费全文 | 2007篇 |
免费 | 87篇 |
国内免费 | 10篇 |
专业分类
耳鼻咽喉 | 9篇 |
儿科学 | 145篇 |
妇产科学 | 62篇 |
基础医学 | 232篇 |
口腔科学 | 51篇 |
临床医学 | 122篇 |
内科学 | 273篇 |
皮肤病学 | 43篇 |
神经病学 | 102篇 |
特种医学 | 183篇 |
外国民族医学 | 1篇 |
外科学 | 265篇 |
综合类 | 55篇 |
预防医学 | 161篇 |
眼科学 | 8篇 |
药学 | 67篇 |
中国医学 | 1篇 |
肿瘤学 | 324篇 |
出版年
2021年 | 13篇 |
2019年 | 12篇 |
2018年 | 15篇 |
2017年 | 16篇 |
2016年 | 22篇 |
2015年 | 32篇 |
2014年 | 24篇 |
2013年 | 46篇 |
2012年 | 55篇 |
2011年 | 63篇 |
2010年 | 45篇 |
2009年 | 65篇 |
2008年 | 57篇 |
2007年 | 63篇 |
2006年 | 75篇 |
2005年 | 71篇 |
2004年 | 77篇 |
2003年 | 79篇 |
2002年 | 69篇 |
2001年 | 63篇 |
2000年 | 69篇 |
1999年 | 69篇 |
1998年 | 75篇 |
1997年 | 74篇 |
1996年 | 69篇 |
1995年 | 47篇 |
1994年 | 51篇 |
1993年 | 54篇 |
1992年 | 31篇 |
1991年 | 31篇 |
1990年 | 38篇 |
1989年 | 45篇 |
1988年 | 45篇 |
1987年 | 54篇 |
1986年 | 49篇 |
1985年 | 37篇 |
1984年 | 28篇 |
1983年 | 20篇 |
1982年 | 34篇 |
1981年 | 13篇 |
1980年 | 21篇 |
1979年 | 18篇 |
1978年 | 12篇 |
1977年 | 14篇 |
1976年 | 12篇 |
1975年 | 12篇 |
1973年 | 18篇 |
1972年 | 9篇 |
1971年 | 14篇 |
1968年 | 9篇 |
排序方式: 共有2104条查询结果,搜索用时 15 毫秒
81.
82.
83.
84.
V Ramesh M Ramam MR Capoor S Sugandhan J Dhawan G Khanna 《Journal of the European Academy of Dermatology and Venereology》2010,24(10):1220-1225
Background Subcutaneous zygomycosis is an uncommon condition observed in tropics. Few series have been published, particularly from the northern regions of India. Objectives The aim of this study was to describe clinical, investigative and therapeutic details in subcutaneous zygomycosis observed in two teaching hospitals in Delhi. Patients and methods Ten patients seen over a period of 10 years (1999–2009) form the material for this report. Results There were four children and six adults. In four children, the presentation was a subcutaneous localized mass or gradually spreading plaque. In the others, it was observed over nasal region of face, spreading inward into mucosal sites and paranasal sinuses, and outward to the contiguous areas. Regional lymphadenopathy was present in two with facial lesions. Majority showed a granulomatous infiltrate with admixture of other cells, mainly eosinophils. Aseptate or poorly septate hyphae were observed in seven. In one patient in whom no hyphae were observed, there was dense perivascular inflammation. Organisms were cultured from four patients, Basidiobolus ranarum in two and Syncephalastrum racemosum in two. The main therapy used was a saturated solution of potassium iodide (KI). Four received only KI of which two attained cure after 3 months and 9 months respectively, and the other two showed signs of regression. In one boy subsidence was associated with reduced circumference of thigh. Ketoconazole or itraconazole was given with KI to hasten regression when response was slow or there were side‐effects to KI. Conclusion Awareness and early recognition will prevent disfigurement produced by advanced disease, misdiagnosis and unnecessary surgical intervention. 相似文献
85.
Genetic variants in cell cycle control pathway confer susceptibility to lung cancer. 总被引:1,自引:0,他引:1
Wei Wang Margaret R Spitz Hushan Yang Charles Lu David J Stewart Xifeng Wu 《Clinical cancer research》2007,13(19):5974-5981
PURPOSE: To test the hypothesis that common sequence variants of cell cycle control genes may affect lung cancer predisposition. EXPERIMENTAL DESIGN: We explored lung cancer risk associations of 11 polymorphisms in seven cell cycle genes in a large case-control study including 1,518 Caucasian lung cancer patients and 1,518 controls. RESULTS: When individuals with variant-containing genotypes were compared with homozygous wild-type carriers, a significantly increased lung cancer risk was identified for polymorphisms in p53 intron 6 [rs1625895; odds ratio (OR), 1.29; 95% confidence interval (95% CI), 1.08-1.55] and in p27 5' untranslated region (UTR; rs34330; OR, 1.27; 95% CI, 1.01-1.60). Compared with homozygous wild-types, the homozygous variant genotypes of STK15 F31I and CCND1 G870A were associated with a significantly altered lung cancer risk with ORs of 0.58 (95% CI, 0.37-0.90) and 1.26 (95% CI, 1.03-1.53), respectively. To assess the cumulative effects of all the investigated polymorphisms on lung carcinogenesis, we conducted a combined analysis and found that compared with low-risk individuals with few adverse alleles, individuals with more adverse alleles had an increased risk in a significant dose-dependent manner (P(trend) = 0.041). This pattern was more evident in ever smokers (P(trend) = 0.037), heavy smokers (P(trend) = 0.020), and older subjects (P(trend) = 0.011). Higher-order gene-gene interactions were evaluated using the classification and regression tree analysis, which indicated that STK15 F31I and p53 intron 6 polymorphisms might be associated with lung carcinogenesis in never/light-smokers and heavy smokers, respectively. CONCLUSIONS: Our results suggest that cell cycle gene polymorphisms and smoking may function collectively to modulate the risk of lung cancer. 相似文献
86.
Jinliang Xing Yong Zhu Hua Zhao Hushan Yang Meng Chen Margaret R Spitz Xifeng Wu 《Cancer epidemiology, biomarkers & prevention》2007,16(3):606-609
Expression of telomerase is one of the hallmarks of tumor cells and has been used as a diagnostic biomarker and a therapeutic target in cancer. Novel findings have shown that telomerase activation in normal human epithelial cells may affect expression of several cancer-related genes, such as growth-related genes and c-myc gene, suggesting a possible role of telomerase in tumor initiation. Therefore, we hypothesized that individuals who are sensitive to mutagen challenge in terms of induced telomerase activity might have increased cancer risk. We tested this hypothesis in a bladder cancer case-control study (51 cases and 51 matched controls) by measuring baseline and gamma-radiation-induced telomerase activities in peripheral blood lymphocytes. We found a significantly higher gamma-radiation-induced telomerase activity in bladder cancer cases compared with the controls (1.34 versus 1.23; P = 0.044). A similar finding was also observed using the normalized telomerase activity (ratio of gamma-radiation induced versus baseline; 1.49 versus 1.19; P < 0.001). In further categorizing the telomerase activity using 75% of the normalized value in the controls as a cutoff point, we found a significantly increased risk for bladder cancer associated with higher induced telomerase activity (adjusted odds ratio, 3.62; 95% confidence interval, 1.38-9.51). In quartile analysis, a dose-response association was noted between the induced telomerase activity and increased bladder cancer risk (P(trend) = 0.005). Our findings provide the first evidence linking the mutagen-induced telomerase activity in peripheral blood lymphocytes to the risk of bladder cancer, which warrants further investigation in large-sized studies and other cancer types. 相似文献
87.
R Frydman C Cornel D de Ziegler J Taieb I M Spitz P Bouchard 《Fertility and sterility》1991,56(5):923-927
OBJECTIVE: To report a preliminary study on the efficacy of a gonadotropin-releasing hormone antagonist (Nal-Glu) for preventing premature luteinizing hormone (LH) and progesterone (P) rise in controlled ovarian hyperstimulation using clomiphene citrate (CC) and human menopausal gonadotropin (hMG). DESIGN: Participants in the study formed two groups. Both groups received CC-hMG and Nal-Glu. Group II differs from group I for receiving human chorionic gonadotropin (hCG) and blood samples for 10 days after the second Nal-Glu injection. SETTING: Centre de Fecondation in Vitro, H?pital Antoine Béclère. PATIENTS: Eleven women 25 to 34 years of age and having normal menstrual cycles using barrier method of contraception not attempting pregnancies participated in the study. INTERVENTION: Daily blood samples, pelvic ultrasound, and CC-hMG/Nal-Glu/hCG administration. MAIN OUTCOME MEASURES: (1) Spontaneous LH surge and P rise, follicular growth, and plasma E2 levels in cycles with CC-hMG/Nal-Glu administration and (2) luteal phase after hCG injection in subjects previously treated with CC-hMG/Nal-Glu. RESULTS: Plasma E2 level increased from 983 +/- 80 pg/mL (mean +/- SEM) on the day of the first Nal-Glu administration to 1,159 +/- 102 and 1,610 +/- 114 pg/mL (mean +/- SEM) 24 and 48 hours later. In 10 women, LH and P remained low for at least 96 hours after the first Nal-Glu administration. In one subject, plasma LH was already elevated at the time of the first Nal-Glu injection. In women who received hCG, plasma E2 and P reached a maximum of 1,258 +/- 313 pg/mL and 50.3 +/- 12.8 ng/mL (mean +/- SEM), respectively, on the 6th day of the luteal phase. CONCLUSION: Our results suggest that timely Nal-Glu injections can prevent LH and P rise for at least 96 hours, in spite of increasing levels of plasma E2. Moreover, Nal-Glu had no adverse effect on the kinetic of E2 rise, the follicular growth, or on the post-hCG hormonal profile. 相似文献
88.
89.
Predictive value of increased plasma levels of fibronectin in gestational hypertension 总被引:4,自引:0,他引:4
V Ballegeer B Spitz L Kieckens H Moreau A Van Assche D Collen 《American journal of obstetrics and gynecology》1989,161(2):432-436
Blood pressure, proteinuria, and plasma fibronectin and plasminogen activator inhibitor-1 levels were measured in 120 apparently healthy normotensive primigravid women during the first, second, and third trimesters of pregnancy and 2 days post partum. Thirty-two women developed hypertension (diastolic blood pressure greater than or equal to 90 mm Hg) that in 17 women was associated with proteinuria (greater than 0.3 gm/day). Fibronectin levels were 83% +/- 22% of normal (mean +/- SD) during the first trimester and 75% +/- 20% at term in the healthy women but increased from 94% +/- 36% to 187% +/- 36% in the women who developed gestational hypertension (with or without proteinuria) (p less than 0.0001). Plasminogen activator inhibitor-1 levels increased from 26 +/- 19 ng/ml to 110 +/- 86 ng/ml in healthy women and from 32 +/- 35 ng/ml to 290 +/- 90 ng/ml in hypertensive women (p less than 0.001). Increased levels of fibronectin at 25 to 36 weeks of pregnancy (greater than or equal to mean + 2 SD of the healthy women, or greater than 140%) were found in 31 of the 32 women with gestational hypertension with or without proteinuria and in 5 of the 88 healthy women (sensitivity 96%, specificity 94%). Fibronectin levels increased 3.6 +/- 1.9 weeks earlier than the onset of hypertension and/or proteinuria. Increased levels of plasminogen activator inhibitor-1 at 25 to 32 weeks (greater than or equal to 280 ng/ml) were found in 16 of the 32 women who developed gestational hypertension with or without proteinuria and in 4 of the 88 healthy women (sensitivity 50%, specificity 95%). We conclude that increased fibronectin levels are the best predictor of gestational hypertension with or without proteinuria and that its level in plasma increases several weeks before the development of hypertension. 相似文献
90.
A race-specific genetic polymorphism in the CYP1A1 gene is not associated with lung cancer in African Americans 总被引:2,自引:0,他引:2
In a case-control study, we tested the hypothesis that a previouslydescribed African American-specific polymorphism in an intron3' to the coding region of the CYP1A1 gene was associated withthe occurrence of lung cancer. The study population included72 African Americans with newly diagnosed, untreated lung cancerwho presented to collaborating clinicians at the Universityof Texas M.D.Anderson Cancer Center and from county, communityand Veterans Administration hospitals in the Houston metropolitanarea. Controls were 97 African Americans, frequency-matchedon gender and age, recruited from community centers, churches,cancer screening programs and from among hospital employees.The prevalence of the variant CYP1A1 genotype did not differbetween the cases and controls. The odds ratio for individualswith one or more copies of the variant allele was 0.64 [ 95%confidence interval (CI) 0.3 1.4]. Overall, 20.7% ofthe population had one or more variant alleles; the prevalencein cases was 16.7% and in controls it was 23.7%. Two individualswith the homozygous variant genotype were controls while oneindividual with lung cancer was found to have the homozygousvariant genotype. The lack of an association between genotypeand lung cancer persisted after subgroup analysis for lifetimecigarette smoking history and tumor histology was performed.The sample size of this study is sufficient to detect odds ratiosof three or greater; associations of this magnitude are similarto those reported in studies of a different polymorphism inthe same region of the CYP1A1 gene in Japanese. Thus, it isunlikely that this polymorphism is associated with sizable risksfor tobacco-induced lung cancer in this population subgroup. 相似文献